0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Combination Chemotherapy of Lymphomas Other Than Hodgkin's Disease

RICHARD S. STEIN, M.D.; EDGAR M. MORAN, M.D.; RICHARD K. DESSER, M.D.; J. BRUCE MILLER, M.D.; HARVEY M. GOLOMB, M.D.; and JOHN E. ULTMANN, M.D., F.A.C.P.
[+] Article and Author Information

Grant support: in part by the Naomi Moos Fund; grant 5 TO 1-AM-05623-05; U.S. Public Health Service; and grant 1/PO1/CA/ 14599-01, National Cancer Institute, National Institutes of Health.

▸Address reprint requests to Dr. John Ultmann, University of Chicago Hospitals, 950 E. 59th St., Chicago, IL 60637.


Chicago, Illinois


Ann Intern Med. 1974;81(5):601-608. doi:10.7326/0003-4819-81-5-601
Text Size: A A A

The efficacy and toxicity of two regimens of combination chemotherapy were compared in patients with lymphoma, other than Hodgkin's disease, in pathologic stage IV. Patients were assigned by unrestricted randomization to receive either vincristine and prednisone or cyclophosphamide, vincristine, procarbazine, and prednisone (COPP). Patients who didn't have complete remission on vincristine and prednisone were switched to COPP. In the randomized trial COPP was superior to vincristine and prednisone, in the rates of induction of complete remission, which were 58% and 14%, respectively (P < 0.005). Of 32 patients receiving COPP, the rate of induction of complete remission was 59% and the median length of complete remission was greater than 18 months. COPP produced a complete remission in 18 of 26 patients with lymphoma other than histiocytic lymphoma. These results compare favorably with those of previously reported regimens. The value of COPP in patients with lymphoma seems to have been shown.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Topic Collections
PubMed Articles

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)